The Case of a Zebra That Was Misdiagnosed as a Horse: Pulmonary Tumor Thrombotic Microangiopathy, a New Paraneoplastic Syndrome, Mimicking PD-1-Induced Pneumonitis
A case report of a 47-year-old woman with triple-negative breast cancer on a clinical trial called PRIMETIME (NCT02518958) who received the anti-PD-1 inhibitor nivolumab and the experimental anticancer agent RRx-001 is presented. Although initially diagnosed and treated for anti-PD-1-induced pneumon...
Main Authors: | Corey A. Carter, Robert Browning, Bryan T. Oronsky, Jan J. Scicinski, Christina Brzezniak |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2016-01-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/443723 |
Similar Items
-
Pulmonary Tumor Thrombotic Microangiopathy: A New Paraneoplastic Syndrome
by: Corey A. Carter, et al.
Published: (2016-04-01) -
COVID‐19‐induced thrombotic microangiopathy: A great mimicker of thrombotic thrombocytopenic purpura (TTP)
by: Brian Warnecke, et al.
Published: (2023-01-01) -
Thrombotic microangiopathy associated with Valproic acid toxicity
by: Sean A. Hebert, et al.
Published: (2017-08-01) -
Thrombotic microangiopathy associated with lenvatinib therapy
by: Macarena Contreras Angulo, et al.
Published: (2023-04-01) -
Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report
by: Mihriban İnözü, et al.
Published: (2022-12-01)